Mesenchymal Stromal Cell-Derived PTX3 Promotes Wound Healing via Fibrin Remodeling

The Journal of Investigative Dermatology
Claudia CappuzzelloGiovanna D'Amico

Abstract

Although mesenchymal stromal cells (MSCs) can promote wound healing in different clinical settings, the underlying mechanism of MSC-mediated tissue repair has yet to be determined. Because a nonredundant role of pentraxin 3 (PTX3) in tissue repair and remodeling has been recently described, here we sought to determine whether MSC-derived PTX3 might play a role in wound healing. Using a murine model of skin repair, we found that Ptx3-deficient (Ptx3(-/-)) MSCs delayed wound closure and reduced granulation tissue formation compared with wt MSCs. At day 2, confocal microscopy revealed a dramatic reduction in green fluorescent protein (GFP)-expressing Ptx3(-/-) MSCs recruited to the wound, where they appeared to be not only poorly organized in bundles but also scattered in the extracellular matrix. These findings were further confirmed by quantitative biochemical analysis of GFP content in wound extracts. Furthermore, Ptx3(-/-) MSC-treated skins displayed increased levels of fibrin and lower levels of D-dimer, suggesting delayed fibrin-rich matrix remodeling compared with control skins. Consistently, both pericellular fibrinolysis and migration through fibrin were found to be severely affected in Ptx3(-/-) MSCs. Overall, our findin...Continue Reading

Citations

Jun 6, 2019·Lasers in Surgery and Medicine·Kamila Pasternak-MnichJolanta Kujawa
Feb 23, 2020·International Journal of Molecular Sciences·Loubna MaziniGabriel Malka
May 3, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A Tuttolomondo, A Pinto
Dec 9, 2015·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jingbo ZhangAbdelilah S Gounni
Apr 11, 2018·Microscopy Research and Technique·Manuel ScimecaElena Bonanno
Apr 26, 2019·Frontiers in Immunology·Andrea DoniBarbara Bottazzi
Dec 4, 2019·Frontiers in Immunology·Raffaella ParenteAntonio Inforzato
Mar 12, 2020·Mycobiology·Yuening KangLiangjing Lu
Apr 16, 2016·Transfusion·Maryanne C Herzig, Andrew P Cap
Jan 25, 2017·International Journal of Molecular Sciences·Meenakshi GaurVictoria V Lunyak
Mar 3, 2020·Frontiers in Bioengineering and Biotechnology·Maria Elisabetta Federica PalamàChiara Gentili
Jul 20, 2017·The Journal of Pathology·Annalisa CapobiancoPatrizia Rovere-Querini
Oct 14, 2017·Immunological Reviews·Marco ErreniPatrizia Rovere-Querini
Oct 13, 2017·Cell Death & Disease·Manuel ScimecaUmberto Tarantino
Feb 8, 2018·Physiological Reviews·Cecilia GarlandaAlberto Mantovani
Apr 8, 2019·International Journal of Cosmetic Science·R SchützD Imfeld
Feb 16, 2021·Frontiers in Immunology·Umberto TarantinoManuel Scimeca
Oct 21, 2017·Vascular Pharmacology·Matteo CasulaFederico Carbone
Nov 30, 2019·Facial Plastic Surgery Clinics of North America·Aunna PourangKian Karimi
Jan 11, 2019·Contrast Media & Molecular Imaging·Manuel ScimecaElena Bonanno
Jun 3, 2021·International Journal of Molecular Sciences·Chiara GreggiUmberto Tarantino
Jun 1, 2021·Frontiers in Immunology·Simone N ZwickyJoel Zindel
Jun 8, 2021·Frontiers in Immunology·Fatemeh AsgariCecilia Garlanda
Jun 22, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Changlin LianHongbo Guo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.